Medpace Holdings, Inc. (MEDP)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Medpace Holdings, Inc. (MEDP)
Company Performance

Current Price

as of Dec 03, 2024

$339.27

P/E Ratio

29.70

Market Cap

$10.55B

Description

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Metrics

Overview

  • HQCincinnati, OH
  • SectorCommercial Services
  • IndustryMiscellaneous Commercial Services
  • TickerMEDP
  • Price$339.27-0.90%

Trading Information

  • Market cap$10.55B
  • Float82.07%
  • Average Daily Volume (1m)368,381
  • Average Daily Volume (3m)385,675
  • EPS$11.83

Company

  • Revenue$2.07B
  • Rev growth (1yr)8.29%
  • Net income$96.43M
  • Gross margin30.28%
  • EBITDA margin22.46%
  • EBITDA$119.79M
  • EV$10.21B
  • EV/Revenue4.93
  • P/E29.70
  • P/S5.26
  • P/B11.94